Assisted Reproductive Technology (ART) Market Size

Pune, India, March 03, 2022 (GLOBE NEWSWIRE) — The world assisted reproductive technology (ART) market size is likely to gain traction due to the increase in infertility cases worldwide. The Centers for Disease Control and Prevention reports that an average of 306,174 ART cycles were started in 2018 at fertility clinics in the United States. According to a recent Fortune Business Insights study titled, “Assisted Reproductive Technology (ART) Market Size, Industry Share, and Analysis, By Technique (In Vitro Fertilization (IVF), Artificial Insemination (AI-IUI), Transfer of ‘frozen embryos (FET) and others), by procedure (fresh donor, fresh non-donor, frozen donor and frozen non-donor), by end user (fertility clinics and hospitals) and regional forecast, 2019-2026”, the market is forecast to reach USD 45.06 billion by the end of 2026, from USD 21.32 billion earned in 2018, growing at a CAGR of 9.8% between 2019 and 2026.

Request a sample copy of the research report:

Regional Analysis-

Europe got the highest share attributed to the increasing prevalence of infertility cases

Geographically, Europe earned $8.78 billion in 2018 and gained the largest ART market share due to the growing prevalence of infertility cases in the region, followed by demand growing use of assisted reproductive technologies for conception. Germany, UK, Spain, France and Denmark are the most active countries for fertility services in this region. Additionally, the North American market will witness significant growth owing to the increasing adoption of technologically advanced fertility services in the United States. In addition, the Asia-Pacific market will also witness rapid growth in the coming years owing to increasing disposable income of people, development of healthcare infrastructure and reduction of socio-ethical stigma among the population. local.

The COVID-19 pandemic has not only impacted our lives on a personal level, but also the global economy as a whole. Most businesses are at a standstill, exporting and importing is not possible, the whole world is in trouble. However, optimism is the faith that leads us to achievement, and so we hope that this biological warfare will end soon with government support and necessary measures. At Fortune Business Insights, we offer detailed analysis of the impact of COVID-19 on various markets for the benefit of market investors.

Click here for the short and long term impact of COVID-19 on this market.
Please visit:

The report answers the following questions

  • What is the nature of the market?
  • How will gamete intrafallopian transfer (GIFT) help in the expansion of the market?
  • What are the major market drivers, restraints and challenges?
  • Which players operate in the market?

Drivers and Constraints-

Increase in cases of infertility in men and women to increase growth

According to the 2018 National Survey of Family Growth (NSFG) report, approximately 6.7% of women between the ages of 15 and 44 suffered from infertility in the United States. This may be due to a change in lifestyle, irregular eating and sleeping habits, thereby depriving the body of full rest, and others. Infertility can also occur in males and hence the increasing rate of infertility in males and females globally is a key factor propelling the growth of the assisted reproductive technology market.

On the negative side, the high cost associated with the treatment may be a major market barrier in the coming years. According to the World Health Organization (WHO), most women residing in emerging countries do not opt ​​for this service due to its high cost. This coupled with the socio-ethical stigma associated with the treatment procedures may also hamper the market in the coming years.

Nevertheless, the advent of various conception techniques such as in vitro fertilization (IVF), intrafallopian gamete transfer (GIFT), artificial insemination (AI-IUI) and frozen embryo transfer (FET), associated to its success rates, are expected to further add impetus to the market in the coming years.

Quick Buy – Assisted Reproductive Technologies Market Research Report:


The in vitro fertilization (IVF) segment dominates due to cost effectiveness

Based on segmentation by technique, the in vitro fertilization (IVF) segment gained 79.2% market share in 20918. This is because a patient may try to opt multiple times for this procedure at a lower cost, thus increasing the chances of pregnancy.

Competitive landscape-

European Sperm Bank, California Cryobank and Bloom IVF Center dominate thanks to a strong portfolio

Players operating in the Assisted Reproductive Technologies (ART) market are engaged in various strategies such as strong network and portfolio, and introduction of more advanced fertility procedures at effective prices to gain traction in the market . Currently, players such as California Cryobank, Bloom IVF Center and European Sperm Bank dominate the market with their strong portfolio.

You have a question ? Ask our experts:

Major industrial developments in the market include:

July 2019 – A Queensland-based fertility service provider called Fertility Solutions has acquired Monash IVF Group to expand its geographic presence.

April 2019 – A significant stake in CARE Fertility has been acquired by Silverfleet Capital Partners with the primary objective of strengthening their portfolio.

Fortune Business Insights™ lists the names of market manufacturers. They are the following:

  • European sperm bank
  • California Cryobank
  • Apollo Hospitals Enterprise Ltd.
  • Bloom IVF Center
  • INVO Biosciences
  • Fertility CARE
  • Carolinas Fertility Institute
  • Monash IVF Group
  • Other players

Get your personalized research report:

Detailed Table of Contents:
1. introduction

1.1. Search scope

1.2. Market segmentation

1.3. Research Methodology

1.4. Definitions and assumptions

2. Abstract

3. Market dynamics

3.1. Market factors

3.2. Market constraints

3.3. Market opportunities

4. key ideas

4.1. Prevalence of infertility, by key regions/countries, 2018

4.2. Number of registered fertility clinics for key countries

4.3. Technological advances in ART procedures

4.4. Key Industry Developments – Partnerships, Mergers & Acquisitions

5. Global Assisted Reproductive Technologies (ART) Market Analysis, Outlook and Forecast, 2015-2026

5.1. Main results/summary

5.2. Market Analysis, Outlook and Forecast – By Technique

5.2.1. In vitro fertilization (IVF)

5.2.2.Artificial insemination (AI-IUI)

5.2.3. Frozen embryo transfer (FET)


5.3. Market Analysis, Outlook and Forecast – By Procedure

5.3.1. Fresh donor

5.3.2. Non-donor fees

5.3.3.Frozen donor

5.3.4. Frozen non-donor

5.4. Market Analysis, Outlook and Forecast – By End User


5.4.2.Fertility clinics

5.5. Market Analysis, Outlook and Forecast – By Region

5.5.1. North America



5.5.4.Latin America

5.5.5. Middle East and Africa


About Us:

Fortune Business Insights™ delivers expert business analysis and accurate data, helping organizations of all sizes make timely decisions. We adapt innovative solutions to our customers, helping them to meet the challenges specific to their activities. Our goal is to give our clients holistic market intelligence, providing granular insight into the market they operate in.

Contact us:

Fortune Business Insights™ Pvt. ltd.
United States: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
E-mail: [email protected]
Fortune Business Insight™
LinkedIn | Twitter | Blogs

Back To Top